Intercept Pharmaceuticals Inc is categorized under in New York City, NY .
| Business Name: | Intercept Pharmaceuticals Inc |
| Contact Person: | Mark Pruzanski, Chief Executive Officer |
| Address: | 18 Desbrosses St Front 1, New York City, New York 10013 |
| Phone Number: | (646) 747-1000 |
| Website Address: | interceptpharma.com |
| Annual Revenue (USD): | Unknown |
| Founding Year: | 2002 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 2834 |
| NAICS Code: | 4461100 |
| Share This Business: | |
| Related Businesses: |
Intecept Pharmaceuticals Inc - New York City, NY 10013 Ventrus Biosciences Inc - New York City, NY 10013 |
The company Intercept Pharmaceuticals Inc provides BOTH services in the form of from its headquarters in New York. 1 to 4 employees work for Intercept Pharmaceuticals Inc, and the business now earns Unknown per annum.
Intercept Pharmaceuticals Inc was launched in 2002 and is classified under SIC code and category 2834 , and NAICS number and grouping 4461100 . To contact Intercept Pharmaceuticals Inc, please call Mark Pruzanski, Chief Executive Officer with the phone number (646) 747-1000 or visit its headquarters at 18 Desbrosses St Front 1 in New York City, New York 10013.
The location of the headquarters can also be found using the coordinates 40.723407,-74.00922. Read more details about this business on the webpage interceptpharma.com or follow the company’s social media accounts, on Twitter and on Facebook.